RUNX2 and thyroid cancer: Being tubacin a HDAC6 specific inhibitor, these data indicate that HDAC6 is selectively involved in RUNX2 transcription in this thyroid cancer cell line, highlighting a close connection between proliferation inhibition and RUNX2 down-regulation.